Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines

Vaccine

Volumn 35, Issue 17, 2017, Pages 2214-2216

  Kahn, Anna Lea ^a   Kristensen, Debra ^b   Rao, Raja ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b PATH   (United States)

^c BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

Cold chain; Controlled temperature chain; Immunization; Supply chain; Vaccine

Indexed keywords

MENINGOCOCCUS VACCINE; VACCINE;

CONTROLLED TEMPERATURE CHAIN; ENVIRONMENTAL TEMPERATURE; HEALTH CARE DELIVERY; HIGH TEMPERATURE; NOTE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; TEMPERATURE; TEMPERATURE MEASUREMENT; VACCINATION; WORLD HEALTH ORGANIZATION; DEVICES; DRUG STORAGE; ECONOMICS; HUMAN; PROCEDURES; REFRIGERATION; SUPPLY AND DISTRIBUTION; TRENDS; VACCINATION COVERAGE;

DRUG STORAGE; HUMANS; IMMUNIZATION PROGRAMS; REFRIGERATION; TEMPERATURE; VACCINATION COVERAGE; VACCINES;

EID: 85016510835     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.10.091     Document Type: Note

References (7)

1. [1] Controlled temperature chain page. World Health Organization (WHO) website. Available from: < http://www.who.int/immunization/programmes_systems/supply_chain/ctc/en/> [accessed 6 September 2016].
2. [2] WHO. The controlled temperature chain (CTC): Frequently asked questions. Geneva: WHO; Available from: < http://www.who.int/immunization/programmes_systems/supply_chain/resources/Controlled-Temperature-Chain-FAQ.pdf?ua=1> [accessed 12 September 2016].
3. [3] WHO Effective Vaccine Management (EVM) Initiative – Global Data Analysis 2009−2014. Available from: < http://www.who.int/immunization/programmes_systems/supply_chain/evm/en/index4.html> [accessed 6 September 2016].
4. [4] Guichard, S., Hymbaugh, K., Burkholder, B., Diorditsa, S., Navarro, C., Ahmed, S., et al. Vaccine wastage in Bangladesh. Vaccine 28:3 (2010), 858–863, 10.1016/j.vaccine.2009.08.035.
5. [5] Lydon, P., Zipursky, S., Tevi-Benissan, C., Djingarey, M.H., Gbedonou, P., Youssouf, B.O., et al. Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad. Bull World Health Organ 92:2 (2014), 86–92, 10.2471/BLT.13.123471.
6. [6] Matthias, D.M., Robertson, J., Garrison, M.M., Newland, S., Nelson, C., Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine 25:20 (2007), 3980–3986, 10.1016/j.vaccine.2007.02.052.
7. [7] Zipursky, S., Djingarey, M.H., Lodjo, J.C., Olodo, L., Tiendrebeogo, S., Ronveaux, O., Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin. Vaccine 32:13 (2014), 1431–1435, 10.1016/j.vaccine.2014.01.038.